Related references
Note: Only part of the references are listed.Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia
C. Lutz et al.
LEUKEMIA (2013)
Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis
L. Mussolin et al.
LEUKEMIA (2013)
Decoupling of Tumor-Initiating Activity from Stable Immunophenotype in HoxA9-Meis1-Driven AML
Kenneth D. Gibbs et al.
CELL STEM CELL (2012)
Circulating t(2;5)-positive cells can be detected in cord blood of healthy newborns
C. Laurent et al.
LEUKEMIA (2012)
Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma
P. Gelebart et al.
BLOOD CANCER JOURNAL (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research
Anna Golebiewska et al.
CELL STEM CELL (2011)
TCR-dependent transformation of mature memory phenotype T cells in mice
Xi Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment
Faiyaz Notta et al.
SCIENCE (2011)
Vinblastine in Children and Adolescents With High-Risk Anaplastic Large-Cell Lymphoma: Results of the Randomized ALCL99-Vinblastine Trial
Marie-Cecile Le Deley et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development
Sergei Doulatov et al.
NATURE IMMUNOLOGY (2010)
NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner
Yu-Xin Cui et al.
BLOOD (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Efficient tumour formation by single human melanoma cells
Elsa Quintana et al.
NATURE (2008)
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma
James G. Christensen et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors
Cesar Cobaleda et al.
NATURE (2007)
Tumor growth need not be driven by rare cancer stem cells
Priscilla N. Kelly et al.
SCIENCE (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells
SD Turner et al.
LEUKEMIA (2006)
Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma
L Mussolin et al.
LEUKEMIA (2005)
What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?
SD Turner et al.
LEUKEMIA (2005)
A robust method for the amplification of RNA in the sense orientation
NF Marko et al.
BMC GENOMICS (2005)
Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells
RW Georgantas et al.
CANCER RESEARCH (2004)
Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase
SD Turner et al.
ONCOGENE (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors
R Chiarle et al.
BLOOD (2003)
Multipotential stem cells and 'side population' cells
MA Goodell
CYTOTHERAPY (2002)
Share Paper
